Skip to main content
. 2020 Sep 2;14(9):e0008647. doi: 10.1371/journal.pntd.0008647

Table 2. Seroprevalence according to distance to the nearest water source.

n() sero-positive and seroprevalence (%) according to distance to the nearest water source (quartiles) Full Dataset Subset* Subset* adjusted for SES
Q1 Q2 Q3 Q4
n = 566 n = 568 n = 564 n = 565
Pathogen (Age <3, n = 134) (Age <3, n = 138) (Age <3, n = 123) (Age <3, n = 125) Prevalence difference Q4 to Q1 P-value Prevalence difference Q4 to Q1 P-value Prevalence difference Q4 to Q1 P-value
S. enterica (LPS B or D) 112 (20.1%) 150 (26.5%) 173 (30.9%) 182 (32.3%) 12% (2.6, 21.4) 0.012 5.9% (-5, 16.7) 0.289 5.7% (-4.8, 16.1) 0.288
C. trachomatis (pgp3 or CT694) 235 (42.1%) 235 (41.5%) 242 (43.2%) 258 (45.8%) 3.5% (-6.9, 13.9) 0.514 2.2% (-13, 17.4) 0.776 3.9% (-11.6, 19.4) 0.620
C. jejuni (p18 or p39)** 124 (93.2%) 126 (91.3%) 108 (87.8%) 114 (91.2%) -0.6% (-5.8, 4.5) 0.806 -5.1% (-10.3, 0.2) 0.057 -5.2% (-10.5, 0) 0.052
ETEC** 80 (60.2%) 93 (67.4%) 75 (61%) 81 (64.8%) 6.4% (-7, 19.9) 0.350 1.7% (-15.4, 18.9) 0.843 2.3% (-18.3, 23) 0.827
E. histolytica (LecA)** 66 (49.6%) 61 (44.2%) 42 (34.1%) 54 (43.2%) -5.7% (-20.4, 9.1) 0.451 -20% (-43.8, 3.8) 0.100 -20.3% (-46, 5.3) 0.120
C. parvum (cp17 or cp23)** 104 (78.2%) 114 (82.6%) 92 (74.8%) 91 (72.8%) -3.9% (-16.5, 8.6) 0.539 -3.2% (-23.8, 17.3) 0.757 -10.5% (-38, 17.1) 0.458
G. intestinalis (VSP-3 or VSP-5)** 86 (64.7%) 90 (65.2%) 78 (63.4%) 94 (75.2%) 12.7% (2.9, 22.6) 0.011 8.3% (-8.6, 25.3) 0.334 9.1% (-9.1, 27.2) 0.328

All prevalence difference estimates are adjusted for age and account for variation in the standard error due to clustering by community.

*Subset = random 33% of households with socioeconomic status information

** Age restricted to 0–3 years

Quartile 1 (Q1): 11.4m–267m; Quartile 2 (Q2): 268m–472m; Quartile 3 (Q3): 473m–720m; Quartile 4 (Q4): 721–2906m